Wilson Elser helps individuals and organizations transcend challenges and realize goals by offering an optimal balance of legal excellence and bottom-line value.
Wilson Elser is the preeminent defense litigation firm in the United States. At any given time, our more than 900 attorneys are engaged in some 100,000 defense and coverage matters, with many defending clients in various local, state and federal courts. Indeed, over more than four decades, our litigation, coverage and trial lawyers have gained a reputation for taking on and prevailing in the most challenging and technical cases, frequently “parachuting in” to assume unresolved matters from other law firms. Our success also derives from winning on our clients’ terms and rigorously adhering to their guidelines. We are ranked 105 in the Am Law 200 and 57th in the National Law Journal’s NLJ 500.
Since our founding in 1978, Wilson Elser has forged a reputation as a formidable player in insurance coverage and defense. Our experience in this tightly regulated, cost-conscious industry has shaped a firm culture of accomplished professionalism and cost efficiency that delivers demonstrable value to clients.
Today, Wilson Elser provides clients with full-service, first-class legal services, spanning the spectrum of litigation and related areas. We apply the discipline and diligence of effective litigation to virtually all areas of the law, drawing on a comprehensive roster of legal services to create multidisciplinary teams that give each client matter the best of the firm’s collective intelligence and capabilities.
The National Law Review names Wilson Elser Moskowitz Edelman & Dicker LLP a Go-To Thought Leader in cannabis law for the year 2022. In particular, the firm’s coverage of specialty cannabis products, such as Delta-8 and edible THC products, saw a substantial audience this year, serving as a valuable guide for attorneys and professionals in this area. Authors such as Ian A. Stewart and Leia Leitner provided key insights into topics such as the Ninth Circuit Delta-8 ruling, Minnesota’s inadvertent legalization of cannabis edibles, and much more.